Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ACCORD HLTHCARE

  • FDA Approval
  • April 11, 2023, 11:36 UTC
  • 30
  • 0 comments

FDA approve ATROPINE SULFATE

Comment Full text

SHILPA

  • FDA Approval
  • April 11, 2023, 11:36 UTC
  • 29
  • 0 comments

FDA approve APREMILAST

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • April 11, 2023, 11:36 UTC
  • 31
  • 0 comments

FDA approve EFAVIRENZ

Comment Full text

ACTAVIS LABS

  • FDA Approval
  • April 10, 2023, 18:28 UTC
  • 30
  • 0 comments

FDA approve TREPROSTINIL

Comment Full text

XIAMEN LP PHARM CO

  • FDA Approval
  • April 10, 2023, 13:28 UTC
  • 30
  • 0 comments

FDA approve MEMANTINE;DONEPEZIL HYDROCHLORIDES

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • April 10, 2023, 11:44 UTC
  • 30
  • 0 comments

FDA approve LAMIVUDINE; ZIDOVUDINE

Comment Full text

AMGEN INC

  • FDA Approval
  • April 07, 2023, 19:31 UTC
  • 36
  • 0 comments

FDA approve ADALIMUMAB-ATTO

Comment Full text

HOSPIRA

  • FDA Approval
  • April 07, 2023, 11:41 UTC
  • 32
  • 0 comments

FDA approve CIPROFLOXACIN

Comment Full text

HIKMA

  • FDA Approval
  • April 07, 2023, 11:41 UTC
  • 32
  • 0 comments

FDA approve CISATRACURIUM BESYLATE

Comment Full text

HIKMA

  • FDA Approval
  • April 07, 2023, 11:41 UTC
  • 32
  • 0 comments

FDA approve CLINDAMYCIN PHOSPHATE

Comment Full text
  • Previous
  • 845
  • 846
  • 847
  • 848
  • 849
  • Next

Search

News categories

  • Technical Exchange News(12137)
  • Event(5779)
  • SEC News(257801)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(152362)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin